- Home
- MNSB vs MIST Comparison
MNSB vs MIST Comparison
Compare MNSB & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | MIST |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 146.9M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNSB | MIST |
|---|---|---|
| Price | $25.02 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 20.4K | ★ 1.4M |
| Earning Date | 04-20-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 210.00 | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $135,615,000.00 | N/A |
| Revenue This Year | $1.50 | $2,915.14 |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | $23.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.86 | $0.88 |
| 52 Week High | $25.87 | $3.06 |
Technical Indicators
Market Signals| Indicator | MNSB | MIST |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.